The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Sacituzumab govitecan
Australian Public Assessment Report
Device/Product Name
Trodelvy
Active ingredients
Sacituzumab govitecan
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-00038-1-4
Submission Type
New biological entity
Decision
Approved